Amphenol Corporation
—- Market cap
- $103.47B
- Debt
- —
- Cash
- −$11.13B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt cap
Decision snapshot: APH stock price at discount vs HUM $83.92 current versus $139.10 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HUM's multiple
Implied fair value · at APH's multiple
Snapshot Sep 11, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 80% equity / 20% debt · EV / Revenue 0.44x · EV proxy / EBITDA proxy 16.26x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
AMPHENOL CORPORATION · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
HUMANA INC · implied price per share
Bear
$260.99
Base
$299.78
Bull
$352.11
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TE Connectivity plc
APH vs TEL
CORNING INC /NY
APH vs GLW
CommScope Holding Company, Inc.
APH vs COMM
HUBBELL INC
APH vs HUBB
BEL FUSE INC /NJ
APH vs BELFA
VISHAY INTERTECHNOLOGY INC
APH vs VSH
UNITEDHEALTH GROUP INC
APH vs UNH
Elevance Health, Inc.
APH vs ELV
CVS HEALTH Corp
APH vs CVS
Cigna Group
APH vs CI
CENTENE CORP
APH vs CNC
Oscar Health, Inc.
APH vs OSCR
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe APH can sustain its 51.7% revenue growth and 25.4% operating margin, then hold or accumulate on weakness because the business quality is clearly stronger than HUM; if growth normalizes toward HUM-like levels, the current P/E premium and -18.2% implied downside argue for caution.
On the provided P/E basis, APH appears expensive relative to HUM, and the implied price of $134.67 sits 18.2% below the current price of $164.59. However, APH also trades against a very different operating profile, so the apparent discount/premium signal is not fully supported by the broader valuation set.
Supporting Metrics